mdlinx mdlinx
Internal Medicine Articles on MDLinx Top Read Articles
of 2012
« Return to Article Summary

A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study



Article Options

Go To PubMed Read Full Abstract, Find Related Articles, and more ... PubMed Link
Go To Abstract Modern Rheumatology - Read Full Abstract, Access Prior Issues ... Publisher Link
Print Article Summary
Related Articles MDlinx Article Summaries on Similar Topics from Clinician-Valued Journals

1 Use of Lipid-lowering Agents in Rheumatoid Arthritis: A Population-based Cohort Study The Journal of Rheumatology, May 2, 2013
Exclusive Author Commentary

2 Update on the Antimicrobial Management of Foot Infections in Patients With Diabetes Clinical Diabetes, April 18, 2013    Review Article

3 The impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis (RA) vs. non-RA subjects: Results from a population-based study Arthritis Care & Research , April 17, 2013

4 Safety profile of protein kinase inhibitors in rheumatoid arthritis: systematic review and meta-analysis Annals of Rheumatic Diseases, April 22, 2013    Evidence Based Medicine    Review Article

5 Interleukin-6: a new therapeutic target in systemic sclerosis Clinical & Translational Immunology, April 18, 2013    Review Article

6 The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA Annals of Rheumatic Diseases, May 8, 2013

7 MRI-based three-dimensional bone shape of the knee predicts onset of knee osteoarthritis: Data from the Osteoarthritis Initiative Arthritis & Rheumatism, May 6, 2013

8 Psoriasis vulgaris and Psoriasis pustulosa Epidemiology, Quality of Life, Comorbidities and Treatment Current Rheumatology Reviews, April 19, 2013

9 Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients? JAMA, May 15, 2013    Evidence Based Medicine

10 New biologic therapy for systemic lupus erythematosus Current Opinion in Pharmacology , May 10, 2013




Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close